Tag Archives: Advaxis

Fighting Prostate Cancer with Immunotherapy

shutterstock_27291016

Advaxis and UC San Francisco join forces to develop and test a range of novel constructs Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. According to the American Cancer Society, around 230,000 new cases of prostate cancer are diagnosed and 30,000 men die from the disease each year. Cancer immunotherapy offers one promising approach to combating the disease. The University of California, San Francisco, (UCSF) and biotechnology Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,